MoneyWorks4Me

Morepen Laboratories informs about press release

05 May 2022 Evaluate

Morepen Laboratories has informed that it enclosed press release on the financial performance of the Company for the quarter and financial year ended 31st March 2022 with the title 'Morepen Labs Annual FY22 Revenue up by 30% with Profit before Tax (PBT) growth of 29%, API Export registered growth of 17%'.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..